Literature DB >> 17275963

Candidal versus bacterial late-onset sepsis in very low birthweight infants in Israel: a national survey.

Imad R Makhoul1, Yoram Bental, Meir Weisbrod, Polo Sujov, Ayala Lusky, Brian Reichman.   

Abstract

Candidal infections are one of the common causes of late-onset sepsis (LOS) among very low birthweight (VLBW) infants, and are associated with substantial morbidity and mortality. The aim of this study was to evaluate the perinatal and neonatal risk factors for fungal LOS compared with bacterial LOS in VLBW infants. This was a population-based observational study of VLBW infants in 28 neonatal intensive care units across Israel, with information on 11,830 infants born between 1995 and 2002 from the Israeli National VLBW infant database. The study population comprised 3054 infants with one or more episodes of LOS. Univariate analysis and logistic regression models were used to compare perinatal and neonatal risk factors between infants with fungal sepsis only (N=179) and those with bacterial sepsis only (N=2630). The mean birthweight and gestational age of infants with candidal LOS were significantly lower (940 g; 27.1 weeks) than those in the bacterial LOS group (1027 g; 28.3 weeks) (P<0.001). Logistic regression analysis showed that candidal sepsis, in contrast to bacterial sepsis, was independently associated with decreasing gestational age and bronchopulmonary dysplasia (BPD). In addition, BPD only [odds ratio (OR) 1.84; 95% confidence intervals (CI) 1.03-3.23] and BPD with postnatal steroid therapy (OR 2.66; 95% CI 1.59-4.46) were independently associated with an increased risk for candidal sepsis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17275963     DOI: 10.1016/j.jhin.2006.12.004

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  8 in total

1.  Targeted fluconazole prophylaxis for high-risk very low birth weight infants.

Authors:  Asaph Rolnitsky; Itzhak Levy; Lea Sirota; Itamar Shalit; Gil Klinger
Journal:  Eur J Pediatr       Date:  2012-05-25       Impact factor: 3.183

Review 2.  Triazole use in the nursery: fluconazole, voriconazole, posaconazole, and ravuconazole.

Authors:  Kevin Watt; Paolo Manzoni; Michael Cohen-Wolkowiez; Stefano Rizzollo; Elena Boano; Evelyne Jacqz-Aigrain; Daniel K Benjamin
Journal:  Curr Drug Metab       Date:  2013-02       Impact factor: 3.731

Review 3.  Clinical aspects of invasive candidiasis in paediatric patients.

Authors:  Elio Castagnola; Silvia Buratti
Journal:  Drugs       Date:  2009       Impact factor: 9.546

4.  The use of ciprofloxacin and fluconazole in Italian neonatal intensive care units: a nationwide survey.

Authors:  Chiara Pandolfini; Sequi Marco; Manzoni Paolo; Bonati Maurizio
Journal:  BMC Pediatr       Date:  2013-01-07       Impact factor: 2.125

5.  Role of probiotics in the prevention of the enteric colonization by Candida in preterm newborns: incidence of late-onset sepsis and neurological outcome.

Authors:  M G Romeo; D M Romeo; L Trovato; S Oliveri; F Palermo; F Cota; P Betta
Journal:  J Perinatol       Date:  2010-04-22       Impact factor: 2.521

6.  Neonatal gram negative and Candida sepsis survival and neurodevelopmental outcome at the corrected age of 24 months.

Authors:  Timo R de Haan; Loes Beckers; Rogier C J de Jonge; Lodewijk Spanjaard; Letty van Toledo; Dasja Pajkrt; Aleid G van Wassenaer-Leemhuis; Johanna H van der Lee
Journal:  PLoS One       Date:  2013-03-18       Impact factor: 3.240

7.  Successful management of an extremely premature infant with congenital candidiasis.

Authors:  Sota Iwatani; Yuko Murakami; Masami Mizobuchi; Kazumichi Fujioka; Keiko Wada; Hitomi Sakai; Seiji Yoshimoto; Hideto Nakao
Journal:  AJP Rep       Date:  2013-12-12

8.  Late-Onset Sepsis as a Risk Factor for Bronchopulmonary Dysplasia in Extremely Low Birth Weight Infants: A Nationwide Cohort Study.

Authors:  Euiseok Jung; Byong Sop Lee
Journal:  Sci Rep       Date:  2019-10-29       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.